Queen Mary University of London
REMASK trial is a Trial within Cohort study (TwiCs), nested within the COVIDENCE UK longitudinal study. It has been designed to determine whether the offer of a free reusable, elastomeric face mask to adults with asthma and other members of their household reduces risk of RT-PCR confirmed viral respiratory infections and asthma exacerbations.
Acute Respiratory Infection
Asthma Exacerbations
FloMask - reuseable face mask
PHASE2
Study Type : | INTERVENTIONAL |
Estimated Enrollment : | 290 participants |
Masking : | NONE |
Primary Purpose : | PREVENTION |
Official Title : | Reuseable Face Masks to Reduce Risk of Viral Respiratory Infections and Exacerbations in Adults With Asthma: a Randomised Controlled Trial |
Actual Study Start Date : | 2025-04 |
Estimated Primary Completion Date : | 2026-05 |
Estimated Study Completion Date : | 2026-05 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 16 Years |
Sexes Eligible for Study: | ALL |
Accepts Healthy Volunteers: | 1 |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
Queen Mary University of London
London, Greater London, United Kingdom,